IRIS
AIMARETTI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.210
NA - Nord America 5.149
AS - Asia 1.362
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 8
AF - Africa 4
Totale 12.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.113
IE - Irlanda 2.166
DE - Germania 978
SE - Svezia 882
UA - Ucraina 777
IT - Italia 718
CN - Cina 511
FI - Finlandia 435
HK - Hong Kong 271
SG - Singapore 215
IN - India 171
FR - Francia 77
VN - Vietnam 77
GB - Regno Unito 61
IR - Iran 51
CA - Canada 36
NL - Olanda 35
CZ - Repubblica Ceca 27
BE - Belgio 24
EU - Europa 23
TR - Turchia 14
BR - Brasile 13
JP - Giappone 9
PE - Perù 9
PK - Pakistan 9
AU - Australia 8
KR - Corea 7
MY - Malesia 7
ES - Italia 4
GR - Grecia 4
IL - Israele 4
MO - Macao, regione amministrativa speciale della Cina 4
PH - Filippine 4
RO - Romania 4
RU - Federazione Russa 4
CL - Cile 3
LT - Lituania 3
TH - Thailandia 3
AR - Argentina 2
BD - Bangladesh 2
CH - Svizzera 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
KE - Kenya 1
KW - Kuwait 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PL - Polonia 1
SN - Senegal 1
TG - Togo 1
Totale 12.784
Salva come PNG Salva come JPEG
Città #
Dublin 2.159
Jacksonville 1.476
Dearborn 696
Wilmington 432
Chandler 289
Lawrence 275
Princeton 275
Hong Kong 261
San Mateo 215
Beijing 214
Andover 157
Ann Arbor 152
Singapore 124
Ashburn 121
Piemonte 105
Bremen 99
Dong Ket 74
Milan 53
Turin 52
Hefei 46
Boardman 40
Norwalk 40
Houston 38
Düsseldorf 37
Philadelphia 36
Kunming 35
Novara 35
Nanjing 30
Fairfield 29
Helsinki 28
Brno 27
Woodbridge 24
Munich 23
Torino 23
Brussels 22
Zanjan 22
Nanchang 21
Cassano Magnago 19
Monmouth Junction 19
Paris 19
Leawood 17
Toronto 17
Rome 16
Alessandria 15
Jinan 15
Dronten 14
Kocaeli 13
Guangzhou 12
Zhengzhou 12
Ardabil 11
Bologna 11
West Jordan 10
Chennai 9
Fuzhou 9
Shenyang 9
Augusta 8
Grafing 8
Montreal 8
Seattle 8
São Paulo 8
Borgo Vercelli 7
Sham Shui Po 7
Sydney 7
Berlin 6
Hebei 6
Naples 6
Shaoxing 6
Wuhan 6
Baotou 5
Chimbote 5
London 5
Napoli 5
Nardò 5
Palermo 5
Strasbourg 5
Xian 5
Cambridge 4
Changsha 4
Dallas 4
Lima 4
Macao 4
New York 4
Pescantina 4
Redwood City 4
San Diego 4
Senigallia 4
Shanghai 4
Tehran 4
Trivero 4
Vercelli 4
Winnipeg 4
Agrate Conturbia 3
Athens 3
Bangkok 3
Bari 3
Bien Hoa 3
Busanjin-gu 3
Casalecchio Di Reno 3
Chengdu 3
Cuggiono 3
Totale 8.250
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 213
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 140
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 98
Change over time of COVID-19 hospital presentation in Northern Italy 92
Molecular analysis of the Growth Hormone Releasing Hormone Receptor (GHRH-R) gene in Isolated Growth Hormone Deficiency (IGHD): identification of a likely etiological mutation in the signal peptide. 90
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 89
Evaluation of the short-term effects of dietary supplement “Flebotrofine” on markers of endothelial dysfunction in type 2 diabetes patients: a pilot study. 88
Autophagy and thyroid carcinogenesis: genetic and epigenetic links 86
Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy 85
Identification of Haptoglobin as a Readout of rhGH Therapy in GH Deficiency 85
Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man. 84
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 78
Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency. 77
Influence of UV radiation on the association between 25-hydroxy vitamin D levels and cardiovascular risk factors in obesity. 77
Effects of phenylalanine, histidine, and leucine on basal and GHRH-stimulated GH secretion and on PRL, insulin, and glucose levels in short children. Comparison with the effects of arginine. 75
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 74
Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin 73
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 72
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. 69
Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life 69
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 69
MOLECULAR ANALYSIS OF THE GROWTH HORMONE GENE IN ISOLATED GROWTH HORMONE DEFICIENCY: POSSIBILE INVOLVEMENT OF A PROMOTER POLYMORPHISM 68
Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. 67
Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS) 67
How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings? 67
Targeting microbiota in dietary obesity management: a systematic review on randomized control trials in adults 65
Thyroid cancer phenotypes in relation to inflammation and autoimmunity 65
Transsphenoidal surgery for pituitary adenomas: early results from a single center 65
Appropriate use of stimulation tests and insulin-like growth factor-I in obesity 64
GHRH an GH secretagogues: clinical perspectives and safety. 64
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. 63
Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. 63
Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism 63
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 63
Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: Association with insulin sensitivity and metabolic alterations. 63
Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood. 62
New approach to the diagnosis of growth hormone deficiency in adults. 61
Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. 61
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. 61
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 60
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 60
Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents 60
Acylated and unacylated ghrelin levels in normal weight and obese children: influence of puberty and relationship with insulin, leptin and adiponectin levels. 60
Ovotesticular Disorder of Sex Development: A Rare Case of Lateral Subtype 45X/46XY kariotype Diagnosed in Adulthood 60
Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy 60
Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome 60
IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency. 59
DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement. 59
One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study. 59
Adrenal sensitivity to ACTH1-24 as function of age, body weight and pituitary function. 59
Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height. 59
Embolization for Insulinoma in Complicated Severe Obesity: Description of an Inoperable Case and Review of the Literature 59
THE RELATIONSHIP BETWEEN CORTISOL AND IGF-I INFLUENCES METABOLIC ALTERATION IN PEDIATRIC OVERWEIGHT AND OBESITY 59
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 58
Clinical picture and the treatment of TBI-induced hypopituitarism 58
GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. 57
Unusual metastases from tall cell variant of papillary thyroid cancer 57
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 57
Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity 56
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA. 56
IGF-I levels in prepubertal and pubertal children with Down syndrome. 55
Serum leptin levels are not influenced by arginine and insulin infusion and by acute changes of GH. 55
GHRELIN CONCENTRATIONS IN NORMAL AND OBESE CHILDREN: ROLE OF PUBERTY. 55
High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study. 55
Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiency. 55
Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables 55
Circulating adipokines and metabolic setting in differentiated thyroid cancer 55
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 55
The impact of the metabolic phenotype on thyroid function in obesity 54
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 54
Low dose orally administered arginine is able to enhance both basLow dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. 54
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. 53
Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. 53
Measurement of Height Velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury. 53
Vitamin D as a Biomarker of Ill Health among the Over-50s: A Systematic Review of Cohort Studies. 53
Effectiveness of E-learning training on drug – dosage calculation skills of nursing students: A randomized controlled trial 53
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 53
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. 52
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. 52
A novel compound heterozygous mutation of the aromatase gene in an adult man: new insight into the role of estrogen on gonadal development. 52
The lullaby of the sun: the role of vitamin D in sleep disturbance 52
The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency 51
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome 51
Vitamin D and neurological diseases: An endocrine view 51
Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach 51
GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine. 50
Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span. 50
Preface 50
Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency. 50
Metabolic alterations in patients who develop Traumatic Brain Injury (TBI)-induced hypopituitarism. 50
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 50
Non-surgical ablative therapies for inoperable benign insulinoma 50
Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals 50
Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia 50
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 50
Lymphocytes and immunoglobulin patterns across the threshold of severe obesity 48
Levothyroxine Replacement in Obese Adults: The Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities 48
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 48
Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial 48
Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. 47
Totale 6.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.688 12 7 249 18 436 430 628 117 297 227 264 3
2020/20211.883 254 2 260 6 256 76 280 10 279 49 297 114
2021/20221.909 69 39 305 196 114 25 184 40 137 38 358 404
2022/20233.777 311 176 188 74 226 259 104 128 2.063 31 129 88
2023/20241.332 97 96 75 29 250 43 285 71 23 44 93 226
2024/202559 59 0 0 0 0 0 0 0 0 0 0 0
Totale 13.089